Header image

Proffered Paper Session 02

Monday, May 31, 2021
2:00 PM - 3:36 PM

Speaker

Agenda Item Image
Dr Evan Cunningham
Senior Lecturer Fellow
Unsw/ Kirby Institute

INTERVENTIONS TO ENHANCE TESTING AND TREATMENT UPTAKE FOR HEPATITIS C INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS

2:00 PM - 2:15 PM

Abstract PDF

Biography

Evan is a Lecturer at the Kirby Institute whose research is focused on the elimination of hepatitis C and the improvement of hepatitis C care among vulnerable populations.
Ms Emily Lenton
Research Officer
La Trobe

HEPATITIS C TESTING AND GAINING INFORMED CONSENT: TAKING STOCK AND INNOVATING FOR THE FUTURE

2:15 PM - 2:30 PM

Abstract PDF

Biography

Emily is a Research and Project Officer at the Australian Research Centre in Sex, Health and Society, La Trobe University, working on the design and implementation of qualitative projects that seek to improve the lives of people affected by hepatitis C. Emily has worked extensively in research and workforce development.
Dr Michael Macisaac
Gastroenterology Registrar
St Vincent's Hospital Melbourne

RAPID POINT OF CARE HCV TESTING ALLOWS HIGH THROUGHPUT HCV SCREENING AND RAPID TREATMENT UPTAKE AMONG PWID ATTENDING A MEDICALLY SUPERVISED INJECTING ROOM

2:30 PM - 2:45 PM

Abstract PDF

Biography

Dr Michael MacIsaac is a gastroenterology registrar at St Vincent’s Hospital Melbourne. He is also currently a Master of Philosophy candidate at the University of Melbourne. The focus of his thesis is engagement of marginalised populations in care for hepatitis C.
Agenda Item Image
Prof Jason Grebely
Professor
Unsw/ Kirby Institute

POINT-OF-CARE HCV RNA TESTING, LINKAGE TO NURSING CARE, AND PEER-SUPPORTED ENGAGEMENT AND DELIVERY TO ENHANCE HCV TREATMENT AMONG PEOPLE WITH RECENT INJECTING DRUG USE AT A COMMUNITY-LED NEEDLE AND SYRINGE PROGRAM: THE TEMPO PILOT STUDY

2:45 PM - 3:00 PM

Abstract PDF

Biography

Jason is a Professor and Head of the Hepatitis C and Drug Use Research Group at the Kirby Institute at UNSW Sydney.
Agenda Item Image
Ms Anna Wilkinson
Research Fellow
Macfarlane Burnet Institute

SENTINEL SURVEILLANCE OF HEPATITIS CC ANTIBODY TESTING, VICTORIA, AUSTRALIA, 2009 TO 2019

3:00 PM - 3:05 PM

Abstract PDF

Biography

Ms. Anna Wilkinson is an early career public health researcher, with interests in epidemiology, biostatistics, maximising the use of data, and evaluating public health policy. Anna is currently a Research Fellow at the Burnet Institute, in the Eliminate hepatitis C Australia partnership.
Dr Shelley Walker
Research Officer
Burnet Institute

EXPLORING THE POTENTIAL USE OF NOTIFICATION DATA TO INCREASE HEPATITIS C TREATMENT UPTAKE

3:05 PM - 3:10 PM

Abstract PDF

Biography

Shelley has a background in nursing and community development. She completed her PhD in 2019, which was a study about incarcerated young men. She currently works as a research officer at the Burnet Institute, involved in projects in public health, international development, criminal justice and alcohol and other drugs.
Agenda Item Image
A/Prof Vincent Cornelisse
Staff Specialist
NSW Health

SLIPPING THROUGH THE CRACKS? THE EFFICACY OF OPT-OUT HCV TESTING IN A PRIMARY HEALTH CARE FACILITY SERVING MARGINALISED POPULATIONS

3:10 PM - 3:15 PM

Abstract PDF

Biography

Vincent is a specialist at Kirketon Road Centre (KRC), Kings Cross, Sydney. KRC provides services to prevent and treat HIV/AIDS, sexually transmissible infections and viral hepatitis among "at risk" young people, people who sex work and people who inject drugs. He completed a PhD in sexual health epidemiology in 2018
Ms Dorrit Grimstrup
Prison Transition Coordinator
QuIHN

PRISON TRANSITION PROGRAM, A COMMUNITY-BASED PROGRAM; THAT FACILITATES THE CONTINUITY OF CARE FOR CLIENTS IN DIFFERENT PHASES OF HCV TREATMENT AMONG PEOPLE TRANSITIONING IN OR OUT OF CORRECTIONAL CENTRE IN SOUTH EAST QUEENSLAND

3:15 PM - 3:20 PM

Abstract PDF

Biography

Dorrit has been working with QuIHN since 2016 as a Harm Reduction Worker. In 2019 she was employed to implement a prison transition program where she links clients on Hep C treatment transitioning in or out of prisons for support, treatment and follow up service.
Agenda Item Image
Ms Imogen Elsum
Research Program Manager
Macfarlane Burnet Institute

EVALUATION OF THE ‘PEERS ASSISTING TREATMENT OF HEPATITIS C’ (PATH) MODEL IN A PRIMARY CARE SETTING IN MELBOURNE, AUSTRALIA

3:20 PM - 3:25 PM

Abstract PDF

Biography

Carolyn Weidner has worked in front line services with PWID for over 15 years. She is an experienced peer educator and was awarded the Yarra Drug and Health Forum’s AoD worker of the year in 2020. Imogen Elsum’s work focuses on facilitating access to hepatitis C care for PWID.
Agenda Item Image
Ms Karen McCulloch
Mathematical Modeller
WHO Collaborating Centre For Viral Hepatitis

JURISDICTIONAL DISPARITIES IN PROGRESS TOWARDS IMPROVING THE CASCADE OF CARE FOR CHRONIC HEPATITIS B IN AUSTRALIA

3:25 PM - 3:30 PM

Abstract PDF

Biography

Dr Karen McCulloch is a mathematical modeller with an interest in modelling infectious disease dynamics. Her current research is focused on estimating the current and future burden of chronic hepatitis B infection in Australia to measure progress towards national strategy targets.

Chair

Rosemary Gilliver
Clinical Nurse Consultant
Kirketon Road Centre

Agenda Item Image
Vanessa Towell
Program Manager
WHO Collaborating Centre For Viral Hepatitis


Support

Q&A Login 1

Q&A Login 2

Brooke McClune
Touchpoint

Agenda Item Image
Erica Zarins
Touchpoint

loading